• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BVS

BVS

Bioventus Inc.

NASDAQHealthcareMedical - DevicesUS

USD8.55

+0.44 (+5.43%)

Rating:A-

Company Profile

CEO

Robert E. Claypoole

IPO Date

2021-02-11

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$8.13

Prev. Close

$8.11

Day Low

$8.10

Day High

$8.62

52W Low

$5.81

52W High

$11.25

Market Cap

$0.58B

Volume

1.35M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

28.2%

Avg Negative

1.8%

Avg Neutral

70.1%

News Feed

Bioventus Proceeds with Option Structure Agreement with CartiHeal

GlobeNewsWire·8/30/2021·↑ positive

Bioventus Invests in Trice Medical Minimally Invasive Technologies

GlobeNewsWire·8/25/2021·↑ positive

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

GlobeNewsWire·8/23/2021·
↑ positive

Will a Powerful Acquisition Make This Early 2021 IPO a Buy?

The Motley Fool·8/17/2021·↑ positive

Bioventus Inc. (BVS) CEO Ken Reali on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/10/2021·↓ negative

Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

GlobeNewsWire·7/27/2021·↑ positive

Bioventus Invests in Vaporox

GlobeNewsWire·6/24/2021·↑ positive

Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021

GlobeNewsWire·6/16/2021·↑ positive

Will Bioventus (BVS) Continue to Surge Higher?

Zacks Investment Research·5/27/2021·↑ positive

Bioventus Senior Management to Present at Upcoming Investor Conferences

GlobeNewsWire·5/17/2021·↑ positive